Hansen Bo T
a Department of Research, Cancer Registry of Norway , Oslo , Norway.
Hum Vaccin Immunother. 2016 Jun 2;12(6):1451-3. doi: 10.1080/21645515.2016.1158367. Epub 2016 Mar 22.
Uptake of the HPV vaccine has been lower than the uptake of most other childhood vaccines offered in public programs. Since the HPV vaccine protects against a sexually transmitted virus, one barrier to uptake specific to the HPV vaccine may be the concern that vaccination may encourage risky sexual behaviour. Unanimous findings from recent studies show that HPV vaccination does not lead to sexual risk compensation, which is an important message to parents, clinicians and other decision-makers regarding HPV vaccination. Some issues remain to be investigated, like HPV vaccination and sexual risk compensation among boys.
人乳头瘤病毒(HPV)疫苗的接种率低于公共项目中提供的大多数其他儿童疫苗的接种率。由于HPV疫苗预防的是一种性传播病毒,HPV疫苗特有的一个接种障碍可能是担心接种疫苗会助长危险的性行为。近期研究的一致结果表明,HPV疫苗接种不会导致性风险补偿,这对于家长、临床医生和其他HPV疫苗接种决策者而言是一条重要信息。一些问题仍有待研究,比如男孩中的HPV疫苗接种与性风险补偿情况。